BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 28368791)

  • 1. [Fertility-sparing management of endometrial cancer and atypical hyperplasia].
    Gonthier C; Trefoux-Bourdet A; Luton D; Koskas M
    Gynecol Obstet Fertil Senol; 2017 Feb; 45(2):112-118. PubMed ID: 28368791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.
    Simpson AN; Feigenberg T; Clarke BA; Gien LT; Ismiil N; Laframboise S; Massey C; Ferguson SE
    Gynecol Oncol; 2014 May; 133(2):229-33. PubMed ID: 24561246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.
    Corrado G; Baiocco E; Carosi M; Vizza E
    Fertil Steril; 2008 Nov; 90(5):2006.e5-8. PubMed ID: 18692828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.
    De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni GL; Mangili G; Colombo G; Candiani M
    J Minim Invasive Gynecol; 2015; 22(7):1178-82. PubMed ID: 26092080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia.
    Fan Y; Li X; Wang J; Wang Y; Tian L; Wang J
    Reprod Biol Endocrinol; 2021 Aug; 19(1):118. PubMed ID: 34344384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of hysteroscopic resection of endometrial atypical hyperplasia-endometrioid intraepithelial neoplasia and early-stage cancer in combination with megestrol acetate.
    Masciullo V; Trivellizzi N; Zannoni G; Catena U; Moroni R; Fanfani F; Scambia G
    Am J Obstet Gynecol; 2021 Apr; 224(4):408-410. PubMed ID: 33385345
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fertility sparing management of endometrial adenocarcinoma and atypical hyperplasia: a literature review].
    Koskas M; Yazbeck C; Walker F; Delorme P; Azria E; Luton D; Madelenat P
    Bull Cancer; 2012 Jan; 99(1):51-60. PubMed ID: 22212645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia.
    Harrison RF; He W; Fu S; Zhao H; Sun CC; Suidan RS; Woodard TL; Rauh-Hain JA; Westin SN; Giordano SH; Meyer LA
    Am J Obstet Gynecol; 2019 Nov; 221(5):474.e1-474.e11. PubMed ID: 31128110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Extended endometrial ablation risks in the fertility sparing management of adenocarcinoma and atypical hyperplasia of the endometrium].
    Gonthier C; Luton D; Koskas M
    Gynecol Obstet Fertil; 2015 Mar; 43(3):185-6. PubMed ID: 25708847
    [No Abstract]   [Full Text] [Related]  

  • 10. Updates on Conservative Management of Endometrial Cancer.
    Corzo C; Barrientos Santillan N; Westin SN; Ramirez PT
    J Minim Invasive Gynecol; 2018 Feb; 25(2):308-313. PubMed ID: 28782618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility-Sparing Treatment of Early Endometrial Cancer and Complex Atypical Hyperplasia in Young Women of Childbearing Potential.
    Pronin SM; Novikova OV; Andreeva JY; Novikova EG
    Int J Gynecol Cancer; 2015 Jul; 25(6):1010-4. PubMed ID: 25950126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertility-sparing treatment of endometrial cancer precursors among young women: a reproductive point of view.
    Ricciardi E; Maniglio P; Frega A; Marci R; Caserta D; Moscarini M
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1934-7. PubMed ID: 23242719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women.
    Uccella S; Zorzato PC; Dababou S; Bosco M; Torella M; Braga A; Frigerio M; Gardella B; Cianci S; Laganà AS; Franchi MP; Garzon S
    Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women.
    Shan BE; Ren YL; Sun JM; Tu XY; Jiang ZX; Ju XZ; Zang RY; Wang HY
    Arch Gynecol Obstet; 2013 Nov; 288(5):1115-23. PubMed ID: 23644919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management options and fertility-preserving therapy for premenopausal endometrial hyperplasia and early-stage endometrial cancer.
    Gressel GM; Parkash V; Pal L
    Int J Gynaecol Obstet; 2015 Dec; 131(3):234-9. PubMed ID: 26384790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility preserving management of early endometrial cancer in a patient cohort at the department of women's health at the university of Tuebingen.
    Andress J; Pasternak J; Walter C; Kommoss S; Krämer B; Hartkopf A; Brucker SY; Schönfisch B; Steinmacher S
    Arch Gynecol Obstet; 2021 Jul; 304(1):215-221. PubMed ID: 33606091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacies and pregnant outcomes of fertility-sparing treatment with medroxyprogesterone acetate for endometrioid adenocarcinoma and complex atypical hyperplasia: our experience and a review of the literature.
    Ohyagi-Hara C; Sawada K; Aki I; Mabuchi S; Kobayashi E; Ueda Y; Yoshino K; Fujita M; Tsutsui T; Kimura T
    Arch Gynecol Obstet; 2015 Jan; 291(1):151-7. PubMed ID: 25118836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis.
    Koskas M; Uzan J; Luton D; Rouzier R; Daraï E
    Fertil Steril; 2014 Mar; 101(3):785-94. PubMed ID: 24388202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Conservative treatments for endometrial cancer].
    Eid M; Gonthier C; Bucau M; Koskas M
    Rev Prat; 2022 Sep; 72(7):747-749. PubMed ID: 36511962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and meta-analysis of prognostic factors for remission in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma.
    Guillon S; Popescu N; Phelippeau J; Koskas M
    Int J Gynaecol Obstet; 2019 Sep; 146(3):277-288. PubMed ID: 31197826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.